Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Ondřej Soukup is active.

Publication


Featured researches published by Ondřej Soukup.


MedChemComm | 2015

Tetrazole regioisomers in the development of nitro group-containing antitubercular agents

Galina Karabanovich; Jaroslav Roh; Ondřej Soukup; Ivona Pávková; Markéta Pasdiorová; Vojtěch Tambor; Jiřina Stolaříková; Marcela Vejsova; Kateřina Vávrová; Věra Klimešová; Alexandr Hrabálek

Tetrazole derivatives containing nitro substituents have been identified as promising antitubercular agents. In this study, the antitubercular potency, selectivity and toxicity of tetrazole 1,5- and 2,5-regioisomers were examined. We prepared a series of 1- and 2-alkyl-5-benzylsulfanyl-2H-tetrazoles and their selenium analogs with various nitro group substitutions. These 1,5- and 2,5-regioisomers were isolated and unambiguously identified using 1H and/or 13C NMR. Among the prepared compounds, 1- and 2-alkyl-5-[(3,5-dinitrobenzyl)sulfanyl]-2H-tetrazole derivatives and their selenium bioisosteres showed the highest antimycobacterial activity, with minimal inhibitory concentration (MIC) values of approximately 1 μM (0.37–0.46 μg mL−1) against Mycobacterium tuberculosis CNCTC My 331/88. The 2-alkyl regioisomers exhibited consistently higher antimycobacterial activity and lower in vitro toxicity against a mammalian cell line compared to the 1-alkyl isomers. The antimycobacterial activity of the 2-alkyl regioisomers was less influenced by the type of alkyl substituent in contrast to 1-alkyl isomers. Furthermore, the 3,5-dinitrobenzyl moiety per se is not the carrier of mutagenicity. These findings encourage further optimization of the 2-alkyl chain to improve the pharmacokinetic properties and toxicity of 2-alkyl-5-[(3,5-dinitrobenzyl)sulfanyl]-2H-tetrazole lead compounds.


Military Medical Science Letters | 2015

ACID DISSOCIATION CONSTANTS AND MOLECULAR DESCRIPTORS OF SOME XYLENE LINKED BISPYRIDINIUM OXIMES

Namrata Singh; Ondřej Soukup; Rafael Doležal; Zdeněk Fišar; Bhanushree Gupta; Kallol K. Ghosh; Kamil Kuca

1 Department of Psychiatry, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, KeKarlovu 11, 120 00 Prague 2, Czech Republic 2 Biomedical Research Centre, University Hospital Hradec Kralove, Sokolska 581, 500 05 Hradec Kralove, Czech Republic 3 Department of Toxicology and Military Pharmacy, Faculty of Military Health Sciences, University of Defense, Trebesska 1575, Kralove, Czech Republic 4 School of Studies in Chemistry, Pt. Ravishankar Shukla University, Raipur (C.G.), 492010, India 5 Department of Chemistry, Indian Institute of Technology Kanpur, Kanpur (U.P.), 208016 India


Analytical Letters | 2018

Characterization of the Penetration of the Blood–Brain Barrier by High-Performance Liquid Chromatography (HPLC) Using a Stationary Phase with an Immobilized Artificial Membrane

Rafael Doležal; Natálie Karásková; Karel Musil; Martin Novák; Nadezhda V. Maltsevskaya; Dávid Maliňák; Karel Kolář; Ondřej Soukup; Kamil Kuca; Jana Žďárová Karasová

ABSTRACT The biological activity of drugs on organisms is associated with the pharmacokinetic properties, such as the ability to penetrate through environments of varying polarity such as cellular organelles. In this area, particular attention is turned to the physicochemical properties that determine the potential of drugs to pass across the blood–brain barrier and thus to act on the central nervous system. In this study, special effort has been devoted to the simulation of passive diffusion of seven drugs (propranolol, ibuprofen, atenolol, promazine, chlorpromazine, imipramine, and desipramine) through the blood–brain barrier by high-performance liquid chromatography (HPLC) using a column with an immobilized artificial membrane. Gradient reverse elution was used to develop a linear correlation model for the capacity factors kIAM and the in vivo logarithmic values of brain-to-blood drug concentration ratios (log BB) with R of 0.9851. Eleven additional pharmaceuticals were determined by the same method to predict their potential to penetrate the blood–brain barrier. The reported analytical method represents an alternative tool for rapid and noninvasive assessment of the absorption properties of chemicals, especially for the development of novel drugs. The retention of the studied compounds on the immobilized artificial membrane column was also compared with three other C18-based stationary phases. Herein, the results of the HPLC determination of drugs using an immobilized artificial membrane are briefly discussed with respect to a general application of the method for evaluating a broader spectrum of pharmaceutical compounds.


European Journal of Medicinal Chemistry | 2016

Cardanol-derived AChE inhibitors: Towards the development of dual binding derivatives for Alzheimer's disease.

Laís Flávia Nunes Lemes; Giselle de Andrade Ramos; Andressa Souza de Oliveira; Fernanda Silva; Gina de Castro Couto; Marina da Silva Boni; Marcos Jorge R. Guimarães; Isis Nem de Oliveira Souza; Manuela Bartolini; Vincenza Andrisano; Patrícia Coelho do Nascimento Nogueira; Edilberto R. Silveira; Guilherme D. Brand; Ondřej Soukup; Jan Korábečný; Nelilma C. Romeiro; Newton G. Castro; Maria Laura Bolognesi; Luiz Antonio Soares Romeiro


European Journal of Medicinal Chemistry | 2017

Tacrine-resveratrol fused hybrids as multi-target-directed ligands against Alzheimer's disease

Jakub Jeřábek; Elisa Uliassi; Laura Guidotti; Jan Korábečný; Ondřej Soukup; Vendula Sepsova; Martina Hrabinova; Kamil Kuca; Manuela Bartolini; Luis Emiliano Peña-Altamira; Sabrina Petralla; Barbara Monti; Marinella Roberti; Maria Laura Bolognesi


European Journal of Medicinal Chemistry | 2017

Structure-activity relationship studies on 3,5-dinitrophenyl tetrazoles as antitubercular agents

Jan Němeček; Pavel Sychra; Miloslav Macháček; Markéta Benková; Galina Karabanovich; Klára Konečná; Věra Kavková; Jiřina Stolaříková; Alexandr Hrabálek; Kateřina Vávrová; Ondřej Soukup; Jaroslav Roh; Věra Klimešová


Journal of Applied Biomedicine | 2010

The effect of trimedoxime on acetylcholinesterase and on the cholinergic system of the rat bladder

Ondřej Soukup; Ondřej Holas; Jiří Binder; Kumar Killy; Gunnar Tobin; Daniel Jun; Josef Fusek; Kamil Kuca


Molecular BioSystems | 2016

Assessment of DNA-binding affinity of cholinesterase reactivators and electrophoretic determination of their effect on topoisomerase I and II activity

Jana Janockova; E. Zilecka; Jana Kasparkova; Viktor Brabec; Ondřej Soukup; Kamil Kuca; Maria Kozurkova


Military Medical Science Letters | 2012

SYNTHESIS OF THE ISOQUINOLINIUM SALTS DIFFERING IN THE LENGTH OF THE SIDE ALKYLATING CHAIN

Jan Marek; Petr Stodůlka; Ondřej Soukup; Kamil Musilek; Jiří Cabal; Kamil Kuca


MMSL | 2018

ACETYLCHOLINESTERASE REACTIVATORS BASED ON OXIME-FUNCTIONALIZED BIODEGRADABLE IONIC LIQUIDS

Yevgen Karpichev; Illia V. Kapitanov; Nicholas Gathergood; Ondřej Soukup; Vendula Hepnarova; Daniel Jun; Kamil Kuca

Collaboration


Dive into the Ondřej Soukup's collaboration.

Top Co-Authors

Avatar

Kamil Kuca

University of Hradec Králové

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Jan Korábečný

Charles University in Prague

View shared research outputs
Top Co-Authors

Avatar

Jan Marek

University of Ostrava

View shared research outputs
Top Co-Authors

Avatar

Alexandr Hrabálek

Charles University in Prague

View shared research outputs
Top Co-Authors

Avatar

Dávid Maliňák

University of Hradec Králové

View shared research outputs
Top Co-Authors

Avatar

Galina Karabanovich

Charles University in Prague

View shared research outputs
Top Co-Authors

Avatar

Jaroslav Roh

Charles University in Prague

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Kamil Musilek

University of Hradec Králové

View shared research outputs
Researchain Logo
Decentralizing Knowledge